Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Assessment of Potentially Inappropriate Medication Use in Korean Elderly Patients with Parkinson's Disease

국내 노인 파킨슨병 환자에서의 잠재적으로 부적절한 약물사용 현황에 대한 연구

  • Received : 2015.10.01
  • Accepted : 2015.11.15
  • Published : 2015.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The present study assessed the prevalence of the potentially inappropriate medication (PIM) use in Korean elderly patients with Parkinson's disease. In addition, this study examined risk factors that affect PIM use. Method: A retrospective, observational study was conducted using Korean National Health Insurance claims database of 2009. PIM use in Parkinson's disease patients aged 65 years or older was examined based on 2012 Beers Criteria. Multivariable logistic regression was conducted to identify risk factors for PIM use. Results: Among 5,277 elderly patients with Parkinson's disease, 88.9% of patients used PIM(s) at least once. The average number of PIM items used per patient was 4.2. PIM use ratio, the proportion of total amount of PIMs to all medications per patient, was 12.6%. Frequently used PIM therapeutic classes were benzodiazepines (32.7%), first-generation antihistamines (19.2%), and prokinetics (17.5%). Individual PIMs most commonly used included chlorpheniramine (11.4%), levosulpiride (10.9%), diazepam (9.0%), and alprazolam (7.6%). Women (odds ratio [OR] 1.14, 95% confidence interval [CI] 1.11-1.16), medical aid (OR 1.18, 95% CI 1.15-1.21), and long-term facilities (OR 2.43, 95% CI 2.22-2.65) were shown to be risk factors associated with PIM use. Of particular, wide variation in PIM use was associated with the types of healthcare facility. Conclusion: The PIM prevalence was very high in elderly Parkinson's disease patients. Nationally effective and systematic efforts to identify and prevent PIM use should be made to ensure patient safety and to improve quality of care in the elderly.

Keywords

References

  1. Elderly statistics 2012. Available at http://kostat.go.kr. (Accessed on Mar 18, 2015).
  2. 2011 Korea Health Panel Survey. Available at https://www.kihasa.re.kr/html/jsp/english/public/view.jsp?bid=30&ano=731&key=&query=&queryString=YmlkPTMwJnBhZ2U9Ng==. (Accessed on Mar 20, 2015).
  3. Health Insurance Review & Assessment Service. Available at http://www.hira.or.kr/dummy.do?pgmid=HIRAA020045030000&cmsurl=/cms/open/04/02/03/03/1332395_24987.html&subject=2014. (Accessed on Apr 8, 2015).
  4. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003;38(8):843-53. https://doi.org/10.1016/S0531-5565(03)00133-5
  5. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004;56(2):163-84. https://doi.org/10.1124/pr.56.2.4
  6. Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007;32(2):113-21. https://doi.org/10.1111/j.1365-2710.2007.00793.x
  7. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008;37(2):138-41. https://doi.org/10.1093/ageing/afm189
  8. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American geriatrics society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 60(4):616-31. https://doi.org/10.1111/j.1532-5415.2012.03923.x
  9. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 medical expenditure panel survey. JAMA 2001;286(22):2823-9. https://doi.org/10.1001/jama.286.22.2823
  10. McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997;156(3):385-91.
  11. Gallagher P, Ryan C, Byrne S, et al. STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46(2):72-83. https://doi.org/10.5414/CPP46072
  12. Rognstad S, Brekke M, Fetveit A, et al. The Norwegian general practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified delphi study. Scand J Prim Health Care 2009;27(3):153-9. https://doi.org/10.1080/02813430902992215
  13. Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for highrisk medication use in Thai older patients. Arch Gerontol Geriatr 2008;47(1):35-51. https://doi.org/10.1016/j.archger.2007.06.006
  14. Ministry of Food and Drug Safety. Handbook of appropriate medication use for elderly 2009.
  15. Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 2010;27(12):947-57. https://doi.org/10.2165/11584850-000000000-00000
  16. Oh JM. Drug use pattern and evaluation for appropriateness in geriatric patients. Ministry of Food and Drug Safety 2004.
  17. Kang IK. Analysis of prescriptions for elderly at primary healthcare using national health insurance database. M.S. Thesis for Sookmyung Women's University. 2006.
  18. Massano J, Bhatia KP. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2012;2(6):a008870. https://doi.org/10.1101/cshperspect.a008870
  19. Muzerengi S, Contrafatto D, Chaudhuri KR. Non-motor symptoms: identification and management. Parkinsonism Relat Disord, 2007; 13(Suppl 3):S450-6. https://doi.org/10.1016/S1353-8020(08)70048-8
  20. De Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525-35. https://doi.org/10.1016/S1474-4422(06)70471-9
  21. Nationwide survey on the prevalence of Parkinson's disease in Korea. Available at http://www.cdc.go.kr/CDC/notice/CdcKrInfo0201.jsp?menuIds=HOME001-MNU1154-MNU0004-MNU1889&cid=1283. (Accessed on Feb 20, 2015).
  22. Williams-Gray CH, Mason SL, Evans JR, et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry, 2013;84(11):1258-64. https://doi.org/10.1136/jnnp-2013-305277
  23. Morgan JC, Currie LJ, Harrison MB, et al. Mortality in levodopatreated Parkinson's disease. Parkinsons Dis 2014;2014:426976.
  24. Akazawa M, Imai H, Igarashi A, et al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 2010;8(2):146-60. https://doi.org/10.1016/j.amjopharm.2010.03.005
  25. Niwata S, Yamada Y, Ikegami N. Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities. BMC Geriatr 2006;6:1-7. https://doi.org/10.1186/1471-2318-6-1
  26. The Korean standard classification of diseases and causes of death 2012. Available at https://kssc.kostat.go.kr:8443/ksscNew_web/link.do?gubun=004#. (Accessed on Jan 5, 2015).
  27. Bae MK, Lee IH, Yoon JH. Assessment of potentially inappropriate medication use in Korean elderly patients with chronic heart failure. Kor J Clin Pharm 2014;24(2):115-25.
  28. Nam JS, Shin WG, Oh JM. Pattern of medications usage and potentially inappropriate medication usage among Korean ambulatory elderly patients based on an explicit criterion. Kor J Clin Phar 2005;15(2):149-59.
  29. Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293(11):1348-58. https://doi.org/10.1001/jama.293.11.1348
  30. Lai HY, Hwang SJ, Chen YC, et al. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese national health insurance program. Clin Ther 2009;31(8):1859-70. https://doi.org/10.1016/j.clinthera.2009.08.023
  31. Baldoni AO, Ayres LR, Martinez EZ, et al. Factors associated with potentially inappropriate medications use by the elderly according to Beers criteria 2003 and 2012. Int J Clin Pharm 2014;36(2):316-24. https://doi.org/10.1007/s11096-013-9880-y
  32. Chang CB, Lai HY, Yang SY, et al. Patient- and clinic visit-related factors associated with potentially inappropriate medication use among older home healthcare service recipients. PLoS One 2014;9(4):e94350. https://doi.org/10.1371/journal.pone.0094350
  33. Jeon GS, Choi ES, Lee HY. Gender-related difference in the utilization of health care services by Korean adults. J Kor Acad Public Health Nurs, 2010;24(2):182-96.
  34. Kim YJ, Jung SY, Choi NK, et al. Benzodiazepine prescription patterns for the elderly patients at ambulatory care in Korea. JPERM 2008;1:60-7.
  35. Chun YS, Suh YW, Lee ES, et al. Medications causing emergency department visits due to adverse drug reactions in Korean geriatric patients. J Kor Soc Health-Syst Pharm 2012;29(3):271-80.
  36. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry, 2001;62(Suppl 21):11-4.
  37. Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006;332(7539):455-9. https://doi.org/10.1136/bmj.38740.439664.DE
  38. Grosset DG, Macphee GJ, Nairn M. Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ 2010;340:b5614. https://doi.org/10.1136/bmj.b5614
  39. Grimes D, Gordon J, Snelgrove B, et al. Canadian guidelines on Parkinson's disease. Can J Neurol Sci 2012;39(4 Suppl 4):S1-30. https://doi.org/10.1017/S031716710001516X
  40. Ferreira JJ, Katzenschlager R, Bloem BR, et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol 2013;20(1):5-15. https://doi.org/10.1111/j.1468-1331.2012.03866.x
  41. National Institute for Health and Care Excellence. Parkinson's disease: Diagnosis and management in primary and secondary care. Available at https://www.nice.org.uk/guidance/cg35. (Assessed on May 10, 2015).
  42. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294(15):1934-43. https://doi.org/10.1001/jama.294.15.1934
  43. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005;353(22):2335-41. https://doi.org/10.1056/NEJMoa052827